Free Trial

Bain Capital Specialty Finance (BCSF) Competitors

Bain Capital Specialty Finance logo
$10.62 -0.16 (-1.48%)
Closing price 03:59 PM Eastern
Extended Trading
$10.72 +0.11 (+0.99%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

BCSF vs. ARCC, CCAP, CGBD, MFIC, and NMFC

Should you buy Bain Capital Specialty Finance stock or one of its competitors? Bain Capital Specialty Finance's main competitors and comparable companies include Ares Capital (ARCC), Crescent Capital BDC (CCAP), Carlyle Secured Lending (CGBD), MidCap Financial Investment (MFIC), and New Mountain Finance (NMFC). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "asset management & custody banks" industry.

How does Bain Capital Specialty Finance compare to Ares Capital?

Bain Capital Specialty Finance (NYSE:BCSF) and Ares Capital (NASDAQ:ARCC) are both finance companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, media sentiment, analyst recommendations, dividends, profitability, risk, institutional ownership and earnings.

In the previous week, Ares Capital had 6 more articles in the media than Bain Capital Specialty Finance. MarketBeat recorded 9 mentions for Ares Capital and 3 mentions for Bain Capital Specialty Finance. Ares Capital's average media sentiment score of 0.62 beat Bain Capital Specialty Finance's score of -0.73 indicating that Ares Capital is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bain Capital Specialty Finance
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Negative
Ares Capital
5 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Bain Capital Specialty Finance presently has a consensus target price of $12.60, suggesting a potential upside of 18.64%. Ares Capital has a consensus target price of $20.60, suggesting a potential upside of 10.99%. Given Bain Capital Specialty Finance's higher probable upside, equities analysts plainly believe Bain Capital Specialty Finance is more favorable than Ares Capital.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bain Capital Specialty Finance
1 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.75
Ares Capital
0 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.73

Ares Capital has a net margin of 30.91% compared to Bain Capital Specialty Finance's net margin of 24.22%. Bain Capital Specialty Finance's return on equity of 10.40% beat Ares Capital's return on equity.

Company Net Margins Return on Equity Return on Assets
Bain Capital Specialty Finance24.22% 10.40% 4.33%
Ares Capital 30.91%9.80%4.50%

Bain Capital Specialty Finance has a beta of 0.6, suggesting that its share price is 40% less volatile than the broader market. Comparatively, Ares Capital has a beta of 0.61, suggesting that its share price is 39% less volatile than the broader market.

27.4% of Ares Capital shares are held by institutional investors. 0.6% of Bain Capital Specialty Finance shares are held by company insiders. Comparatively, 0.5% of Ares Capital shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Ares Capital has higher revenue and earnings than Bain Capital Specialty Finance. Bain Capital Specialty Finance is trading at a lower price-to-earnings ratio than Ares Capital, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bain Capital Specialty Finance$273.24M2.52$98.76M$0.9910.73
Ares Capital$3.05B4.37$1.30B$1.3513.75

Bain Capital Specialty Finance pays an annual dividend of $1.68 per share and has a dividend yield of 15.8%. Ares Capital pays an annual dividend of $1.92 per share and has a dividend yield of 10.3%. Bain Capital Specialty Finance pays out 169.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Ares Capital pays out 142.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Bain Capital Specialty Finance has raised its dividend for 4 consecutive years. Bain Capital Specialty Finance is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

Ares Capital beats Bain Capital Specialty Finance on 14 of the 19 factors compared between the two stocks.

How does Bain Capital Specialty Finance compare to Crescent Capital BDC?

Crescent Capital BDC (NASDAQ:CCAP) and Bain Capital Specialty Finance (NYSE:BCSF) are both small-cap finance companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, dividends, risk, institutional ownership, valuation, analyst recommendations, earnings and media sentiment.

Crescent Capital BDC has a beta of 0.57, suggesting that its share price is 43% less volatile than the broader market. Comparatively, Bain Capital Specialty Finance has a beta of 0.6, suggesting that its share price is 40% less volatile than the broader market.

Bain Capital Specialty Finance has higher revenue and earnings than Crescent Capital BDC. Crescent Capital BDC is trading at a lower price-to-earnings ratio than Bain Capital Specialty Finance, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Crescent Capital BDC$167.29M2.00$34.51M-$0.09N/A
Bain Capital Specialty Finance$273.24M2.52$98.76M$0.9910.73

In the previous week, Bain Capital Specialty Finance had 2 more articles in the media than Crescent Capital BDC. MarketBeat recorded 3 mentions for Bain Capital Specialty Finance and 1 mentions for Crescent Capital BDC. Crescent Capital BDC's average media sentiment score of 0.61 beat Bain Capital Specialty Finance's score of -0.73 indicating that Crescent Capital BDC is being referred to more favorably in the media.

Company Overall Sentiment
Crescent Capital BDC Positive
Bain Capital Specialty Finance Negative

Crescent Capital BDC presently has a consensus price target of $12.63, suggesting a potential upside of 38.89%. Bain Capital Specialty Finance has a consensus price target of $12.60, suggesting a potential upside of 18.64%. Given Crescent Capital BDC's stronger consensus rating and higher possible upside, research analysts clearly believe Crescent Capital BDC is more favorable than Bain Capital Specialty Finance.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Crescent Capital BDC
0 Sell rating(s)
6 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.14
Bain Capital Specialty Finance
1 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.75

Crescent Capital BDC pays an annual dividend of $1.36 per share and has a dividend yield of 15.0%. Bain Capital Specialty Finance pays an annual dividend of $1.68 per share and has a dividend yield of 15.8%. Crescent Capital BDC pays out -1,511.1% of its earnings in the form of a dividend. Bain Capital Specialty Finance pays out 169.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC has increased its dividend for 1 consecutive years and Bain Capital Specialty Finance has increased its dividend for 4 consecutive years. Bain Capital Specialty Finance is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

49.5% of Crescent Capital BDC shares are owned by institutional investors. 1.2% of Crescent Capital BDC shares are owned by company insiders. Comparatively, 0.6% of Bain Capital Specialty Finance shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Bain Capital Specialty Finance has a net margin of 24.22% compared to Crescent Capital BDC's net margin of -2.02%. Bain Capital Specialty Finance's return on equity of 10.40% beat Crescent Capital BDC's return on equity.

Company Net Margins Return on Equity Return on Assets
Crescent Capital BDC-2.02% 9.02% 3.82%
Bain Capital Specialty Finance 24.22%10.40%4.33%

Summary

Bain Capital Specialty Finance beats Crescent Capital BDC on 12 of the 19 factors compared between the two stocks.

How does Bain Capital Specialty Finance compare to Carlyle Secured Lending?

Carlyle Secured Lending (NASDAQ:CGBD) and Bain Capital Specialty Finance (NYSE:BCSF) are both small-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, earnings, dividends, profitability, valuation and risk.

In the previous week, Bain Capital Specialty Finance had 1 more articles in the media than Carlyle Secured Lending. MarketBeat recorded 3 mentions for Bain Capital Specialty Finance and 2 mentions for Carlyle Secured Lending. Carlyle Secured Lending's average media sentiment score of 0.97 beat Bain Capital Specialty Finance's score of -0.73 indicating that Carlyle Secured Lending is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Carlyle Secured Lending
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Bain Capital Specialty Finance
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Negative

Carlyle Secured Lending has a beta of 0.66, indicating that its share price is 34% less volatile than the broader market. Comparatively, Bain Capital Specialty Finance has a beta of 0.6, indicating that its share price is 40% less volatile than the broader market.

24.5% of Carlyle Secured Lending shares are owned by institutional investors. 0.4% of Carlyle Secured Lending shares are owned by insiders. Comparatively, 0.6% of Bain Capital Specialty Finance shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Bain Capital Specialty Finance has higher revenue and earnings than Carlyle Secured Lending. Bain Capital Specialty Finance is trading at a lower price-to-earnings ratio than Carlyle Secured Lending, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Carlyle Secured Lending$255.57M2.81$69.97M$0.5120.43
Bain Capital Specialty Finance$273.24M2.52$98.76M$0.9910.73

Bain Capital Specialty Finance has a net margin of 24.22% compared to Carlyle Secured Lending's net margin of 14.26%. Bain Capital Specialty Finance's return on equity of 10.40% beat Carlyle Secured Lending's return on equity.

Company Net Margins Return on Equity Return on Assets
Carlyle Secured Lending14.26% 8.85% 3.90%
Bain Capital Specialty Finance 24.22%10.40%4.33%

Carlyle Secured Lending presently has a consensus price target of $11.33, indicating a potential upside of 8.77%. Bain Capital Specialty Finance has a consensus price target of $12.60, indicating a potential upside of 18.64%. Given Bain Capital Specialty Finance's higher possible upside, analysts clearly believe Bain Capital Specialty Finance is more favorable than Carlyle Secured Lending.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Carlyle Secured Lending
0 Sell rating(s)
5 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.17
Bain Capital Specialty Finance
1 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.75

Carlyle Secured Lending pays an annual dividend of $1.40 per share and has a dividend yield of 13.4%. Bain Capital Specialty Finance pays an annual dividend of $1.68 per share and has a dividend yield of 15.8%. Carlyle Secured Lending pays out 274.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Bain Capital Specialty Finance pays out 169.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Bain Capital Specialty Finance has raised its dividend for 4 consecutive years. Bain Capital Specialty Finance is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

Bain Capital Specialty Finance beats Carlyle Secured Lending on 12 of the 19 factors compared between the two stocks.

How does Bain Capital Specialty Finance compare to MidCap Financial Investment?

Bain Capital Specialty Finance (NYSE:BCSF) and MidCap Financial Investment (NASDAQ:MFIC) are both small-cap finance companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk, media sentiment and institutional ownership.

Bain Capital Specialty Finance pays an annual dividend of $1.68 per share and has a dividend yield of 15.8%. MidCap Financial Investment pays an annual dividend of $1.24 per share and has a dividend yield of 14.6%. Bain Capital Specialty Finance pays out 169.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. MidCap Financial Investment pays out -344.4% of its earnings in the form of a dividend. Bain Capital Specialty Finance has increased its dividend for 4 consecutive years. Bain Capital Specialty Finance is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Bain Capital Specialty Finance has higher revenue and earnings than MidCap Financial Investment. MidCap Financial Investment is trading at a lower price-to-earnings ratio than Bain Capital Specialty Finance, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bain Capital Specialty Finance$273.24M2.52$98.76M$0.9910.73
MidCap Financial Investment-$11.90M-58.65$63.17M-$0.36N/A

Bain Capital Specialty Finance has a net margin of 24.22% compared to MidCap Financial Investment's net margin of -9.85%. MidCap Financial Investment's return on equity of 11.17% beat Bain Capital Specialty Finance's return on equity.

Company Net Margins Return on Equity Return on Assets
Bain Capital Specialty Finance24.22% 10.40% 4.33%
MidCap Financial Investment -9.85%11.17%4.41%

28.5% of MidCap Financial Investment shares are owned by institutional investors. 0.6% of Bain Capital Specialty Finance shares are owned by company insiders. Comparatively, 0.9% of MidCap Financial Investment shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Bain Capital Specialty Finance currently has a consensus price target of $12.60, suggesting a potential upside of 18.64%. MidCap Financial Investment has a consensus price target of $10.71, suggesting a potential upside of 26.43%. Given MidCap Financial Investment's stronger consensus rating and higher probable upside, analysts plainly believe MidCap Financial Investment is more favorable than Bain Capital Specialty Finance.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bain Capital Specialty Finance
1 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.75
MidCap Financial Investment
1 Sell rating(s)
6 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, MidCap Financial Investment had 1 more articles in the media than Bain Capital Specialty Finance. MarketBeat recorded 4 mentions for MidCap Financial Investment and 3 mentions for Bain Capital Specialty Finance. MidCap Financial Investment's average media sentiment score of -0.56 beat Bain Capital Specialty Finance's score of -0.73 indicating that MidCap Financial Investment is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bain Capital Specialty Finance
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Negative
MidCap Financial Investment
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Negative

Bain Capital Specialty Finance has a beta of 0.6, meaning that its stock price is 40% less volatile than the broader market. Comparatively, MidCap Financial Investment has a beta of 0.62, meaning that its stock price is 38% less volatile than the broader market.

Summary

MidCap Financial Investment beats Bain Capital Specialty Finance on 11 of the 19 factors compared between the two stocks.

How does Bain Capital Specialty Finance compare to New Mountain Finance?

New Mountain Finance (NASDAQ:NMFC) and Bain Capital Specialty Finance (NYSE:BCSF) are both small-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, dividends, earnings, analyst recommendations, profitability, institutional ownership, valuation and risk.

Bain Capital Specialty Finance has lower revenue, but higher earnings than New Mountain Finance. New Mountain Finance is trading at a lower price-to-earnings ratio than Bain Capital Specialty Finance, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
New Mountain Finance$327.08M1.94$16.49M-$0.47N/A
Bain Capital Specialty Finance$273.24M2.52$98.76M$0.9910.73

Bain Capital Specialty Finance has a net margin of 24.22% compared to New Mountain Finance's net margin of -16.78%. New Mountain Finance's return on equity of 10.94% beat Bain Capital Specialty Finance's return on equity.

Company Net Margins Return on Equity Return on Assets
New Mountain Finance-16.78% 10.94% 4.58%
Bain Capital Specialty Finance 24.22%10.40%4.33%

New Mountain Finance pays an annual dividend of $1.00 per share and has a dividend yield of 14.9%. Bain Capital Specialty Finance pays an annual dividend of $1.68 per share and has a dividend yield of 15.8%. New Mountain Finance pays out -212.8% of its earnings in the form of a dividend. Bain Capital Specialty Finance pays out 169.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Bain Capital Specialty Finance has raised its dividend for 4 consecutive years. Bain Capital Specialty Finance is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, New Mountain Finance had 2 more articles in the media than Bain Capital Specialty Finance. MarketBeat recorded 5 mentions for New Mountain Finance and 3 mentions for Bain Capital Specialty Finance. New Mountain Finance's average media sentiment score of -0.35 beat Bain Capital Specialty Finance's score of -0.73 indicating that New Mountain Finance is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
New Mountain Finance
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
2 Very Negative mention(s)
Neutral
Bain Capital Specialty Finance
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Negative

New Mountain Finance presently has a consensus price target of $8.25, suggesting a potential upside of 22.59%. Bain Capital Specialty Finance has a consensus price target of $12.60, suggesting a potential upside of 18.64%. Given New Mountain Finance's stronger consensus rating and higher possible upside, analysts clearly believe New Mountain Finance is more favorable than Bain Capital Specialty Finance.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
New Mountain Finance
1 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.80
Bain Capital Specialty Finance
1 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.75

New Mountain Finance has a beta of 0.6, indicating that its share price is 40% less volatile than the broader market. Comparatively, Bain Capital Specialty Finance has a beta of 0.6, indicating that its share price is 40% less volatile than the broader market.

32.1% of New Mountain Finance shares are held by institutional investors. 14.9% of New Mountain Finance shares are held by insiders. Comparatively, 0.6% of Bain Capital Specialty Finance shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

New Mountain Finance beats Bain Capital Specialty Finance on 10 of the 17 factors compared between the two stocks.

Get Bain Capital Specialty Finance News Delivered to You Automatically

Sign up to receive the latest news and ratings for BCSF and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BCSF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BCSF vs. The Competition

MetricBain Capital Specialty FinanceCapital Markets IndustryFinance SectorNYSE Exchange
Market Cap$699.28M$5.13B$13.37B$22.94B
Dividend Yield15.58%7.60%6.07%3.72%
P/E Ratio10.7330.0424.7228.60
Price / Sales2.521,201.91487.6024.55
Price / Cash5.7547.5845.1337.72
Price / Book0.623.482.714.72
Net Income$98.76M$415.02M$1.32B$1.07B
7 Day Performance-3.93%-0.39%-0.53%0.35%
1 Month Performance-7.85%-2.10%-2.68%-3.80%
1 Year Performance-20.92%10.37%10.00%6.48%

Bain Capital Specialty Finance Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BCSF
Bain Capital Specialty Finance
3.3813 of 5 stars
$10.62
-1.5%
$12.60
+18.6%
-21.3%$699.28M$273.24M10.731,000
ARCC
Ares Capital
3.4658 of 5 stars
$18.64
-1.0%
$20.60
+10.5%
-4.7%$13.38B$1.17B13.814,250
CCAP
Crescent Capital BDC
4.008 of 5 stars
$9.07
+0.6%
$12.63
+39.2%
-33.0%$334.19M$7.13MN/A250
CGBD
Carlyle Secured Lending
2.1469 of 5 stars
$10.50
-0.6%
$12.25
+16.7%
-12.8%$722.45M$48.71M20.592,500
MFIC
MidCap Financial Investment
2.8395 of 5 stars
$8.50
-0.1%
$11.11
+30.7%
-27.2%$700.15M$320.88MN/AN/A

Related Companies and Tools


This page (NYSE:BCSF) was last updated on 10/9/2026 by MarketBeat.com Staff.
From Our Partners